4//SEC Filing
Wei Lin 4
Accession 0001610717-25-000052
CIK 0001628171other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:01 PM ET
Size
6.9 KB
Accession
0001610717-25-000052
Insider Transaction Report
Form 4
Wei Lin
Chief Medical Officer
Transactions
- Award
Common Stock
2025-03-01−20,800→ 91,651 total - Award
Stock Option (Right to Buy)
2025-03-01+72,800→ 72,800 totalExercise: $40.74Exp: 2035-02-28→ Common Stock (72,800 underlying)
Footnotes (2)
- [F1]Includes 70,750 restricted stock units.
- [F2]One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001872772
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 7:01 PM ET
- Size
- 6.9 KB